Health Insurance Innovations (HIIQ) Weakness 'Overdone' - Cantor Fitzgerald

Cantor Fitzgerald analyst Steven Halper was the latest to defend Health Insurance Innovations (NASDAQ: HIIQ) amid concerns about the Trump administration's decision to reduce funding for ACA advertising and navigator program. The analyst reiterated an Overweight rating and price target of $38.00.

"If this is the case, we expect no impact on the demand for non-compliant policies (short-term medical and health benefit plans), which are sold by HIIQ," Halper said.

There are also concerns about legislative efforts to stabilize ACA markets, he notes. "We maintain our view that low-cost, non-compliant plans can play an important role in reducing premium costs to individuals for an appropriate level of coverage, thus benefitting HIIQ."

The analyst is telling the weakness is overdone.

For an analyst ratings summary and ratings history on Health Insurance Innovations click here. For more ratings news on Health Insurance Innovations click here.

Shares of Health Insurance Innovations closed at $33.65 yesterday.

You May Also Be Interested In

• Tesla Nears Unveiling of Radical New ‘Flying’ Roadster - The Information
• Reddit (RDDT) added to S&P 500
• Foot traffic at Taco Bell for week of August 3 down 8%, compared to a near 20% decline in mid-July - Placer.AIdata